Concepedia

Publication | Open Access

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors

DOIFull Paper Access

239

Citations

13

References

2008

Year

Nicola Steele, Jane A. Plumb, Laura Vidal, Jette Tjørnelund, Poul Knoblauch, Annie Rasmussen, Chean Eng Ooi, P. Buhl-Jensen, Robert Brown, T.R. Jeffry Evans,
Clinical Cancer Research

Abstract

I.v. belinostat is well tolerated, exhibits dose-dependent pharmacodynamic effects, and has promising antitumor activity.

References

YearCitations

Page 1